Side effect reducing agent for ribavirin / interferon combination therapy

摘要

An agent for reducing side effects of ribavirin and interferon combination therapy for chronic hepatitis C, comprising as an active ingredient at least one selected from the group consisting of icosapentaic acid (EPA), pharmaceutically acceptable salts and esters thereof, particularly anemia Provide a relief agent.